96 related articles for article (PubMed ID: 10920931)
21. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.
Jäckel MC; Sellmann L; Dorudian MA; Youssef S; Füzesi L
Laryngoscope; 2000 Aug; 110(8):1339-45. PubMed ID: 10942137
[TBL] [Abstract][Full Text] [Related]
23. p53 Gene mutation and genetic instability in superficial multifocal esophageal squamous cell carcinoma.
Fujiki T; Haraoka S; Yoshioka S; Ohshima K; Iwashita A; Kikuchi M
Int J Oncol; 2002 Apr; 20(4):669-79. PubMed ID: 11894109
[TBL] [Abstract][Full Text] [Related]
24. The biological role of the low-affinity p75 neurotrophin receptor in esophageal squamous cell carcinoma.
Okumura T; Tsunoda S; Mori Y; Ito T; Kikuchi K; Wang TC; Yasumoto S; Shimada Y
Clin Cancer Res; 2006 Sep; 12(17):5096-103. PubMed ID: 16951226
[TBL] [Abstract][Full Text] [Related]
25. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
[TBL] [Abstract][Full Text] [Related]
26. The prognostic significance of proliferative activity, apoptosis and expression of DNA topoisomerase II alpha in multimodally-treated oesophageal squamous cell carcinoma.
Rees M; Stahl M; Klump B; Willers R; Gabbert HE; Sarbia M
Anticancer Res; 2001; 21(5):3637-42. PubMed ID: 11848536
[TBL] [Abstract][Full Text] [Related]
27. Expression of apoptotic and cell proliferation regulatory proteins in keratoacanthomas and squamous cell carcinomas of the skin.
Ribeiro D; Narikawa S; Marques ME
Pathol Res Pract; 2008; 204(2):97-104. PubMed ID: 18079070
[TBL] [Abstract][Full Text] [Related]
28. Oncosis in human esophageal squamous cell carcinoma and its relationship with apoptosis and microvessel density.
Zhao GF; Seng JJ; Zhao S; Hu W; Li A; Li XN; Qi Y
Chin Med J (Engl); 2007 Nov; 120(22):1999-2001. PubMed ID: 18067785
[TBL] [Abstract][Full Text] [Related]
29. Accumulation of p53 in esophageal squamous cell carcinoma.
Chino O; Kijima H; Shimada H; Nishi T; Tanaka H; Kise Y; Kenmochi T; Himeno S; Machimura T; Tanaka M; Inokuchi S; Tajima T; Osamura RY; Makuuchi H
Int J Mol Med; 2001 Oct; 8(4):359-63. PubMed ID: 11562772
[TBL] [Abstract][Full Text] [Related]
30. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
[TBL] [Abstract][Full Text] [Related]
31. Preliminary report on the effect of brachytherapy on expression of p53, bc1-2 and apoptosis in squamous cell carcinoma of the oesophagus.
Sur M; Sur RK; Cooper K; Bizos D
S Afr J Surg; 2003 Feb; 41(1):14-20. PubMed ID: 12756868
[TBL] [Abstract][Full Text] [Related]
32. Basaloid squamous cell carcinoma of the esophagus: an immunohistochemical study of 8 cases.
Huang Z; Shen Y; Liang Y; Wu X
Chin Med J (Engl); 2001 Oct; 114(10):1084-8. PubMed ID: 11677772
[TBL] [Abstract][Full Text] [Related]
33. Expression of p53R2 is related to prognosis in patients with esophageal squamous cell carcinoma.
Okumura H; Natsugoe S; Yokomakura N; Kita Y; Matsumoto M; Uchikado Y; Setoyama T; Owaki T; Ishigami S; Aikou T
Clin Cancer Res; 2006 Jun; 12(12):3740-5. PubMed ID: 16778101
[TBL] [Abstract][Full Text] [Related]
34. p53 null mutations detected by a p53 yeast functional assay predict a poor outcome in young esophageal carcinoma patients.
Osugi H; Morimura K; Okuda E; Takemura M; Higashino M; Takada N; Kinoshita H
Int J Oncol; 2002 Sep; 21(3):637-41. PubMed ID: 12168111
[TBL] [Abstract][Full Text] [Related]
35. The expression of p53, p16 proteins and prevalence of apoptosis in oral squamous cell carcinoma. Correlation with mode of invasion grading system.
Tokman B; Gultekin SE; Sezer C; Alpar R
Saudi Med J; 2004 Dec; 25(12):1922-30. PubMed ID: 15711668
[TBL] [Abstract][Full Text] [Related]
36. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
Crowe DL; Sinha UK
Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
[TBL] [Abstract][Full Text] [Related]
37. Detection of p53 gene mutations in human esophageal squamous cell carcinomas using a p53 yeast functional assay: possible difference in esophageal carcinogenesis between the young and the elderly group.
Okuda E; Osugi H; Morimura K; Takada N; Takemura M; Fukushima S; Higashino M; Kinoshita H
Clin Cancer Res; 2001 Mar; 7(3):600-6. PubMed ID: 11297255
[TBL] [Abstract][Full Text] [Related]
38. Molecular and genetic characterization of a non-metastatic human esophageal cancer cell line, T.Tn expressing non-functional mutated p53.
Sakai T; Furihata T; Kawamata H; Omotehara F; Shinagawa Y; Imura J; Kubota K; Terano A; Fujimori T
Int J Oncol; 2002 Sep; 21(3):547-52. PubMed ID: 12168098
[TBL] [Abstract][Full Text] [Related]
39. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
[TBL] [Abstract][Full Text] [Related]
40. Mutational spectra of p53 in geographically localized esophageal squamous cell carcinoma groups in China.
Cao W; Chen X; Dai H; Wang H; Shen B; Chu D; McAfee T; Zhang ZF
Cancer; 2004 Aug; 101(4):834-44. PubMed ID: 15305417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
